Tatjana Vlajnic

Institution: Institute of Pathology, University Hospital Basel

Address:

Schönbeinstrasse 40 4031 Basel

Email: tatjana.vlajnic@usb.ch

Research interests:

Tumor heterogeneity, cancer stem cells, circulating tumor cells, cytopathology

Selected publications:

Ruiz C, Kustermann S, Pietilae E, Vlajnic T, Baschiera B, Arabi L, Lorber T, Oeggerli M, Savic S, Obermann E, Singer T, Rothschild SI, Zippelius A, Roth AB, Bubendorf L. Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer Medicine. PLoS One. 2016 Wetterauer C*, Vlajnic T*, Schüler J, Gsponer JR, Thalmann GN, Cecchini M, Schneider J, Zellweger T, Pueschel H, Bachmann A, Ruiz C, Dirnhofer S, Bubendorf L, Rentsch CA. Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised mice. Prostate. 2015 *equally contributed Maslova K, Kyriakakis E, Pfaff D, Frachet A, Frismantiene A, Bubendorf L, Ruiz C, Vlajnic T, Erne P, Resink TJ, Philippova M. EGFR and IGF-1R in regulation of prostate cancer cell phenotype and polarity: opposing functions and modulation by T-cadherin. FASEB J. 2015 Vlajnic T, Somaini G, Savic S, Barascud A, Grilli B, Herzog M, Obermann EC, Holmes BJ, Ali SZ, Degen L, Bubendorf L. Targeted multiprobe fluorescence in situ hybridization analysis for elucidation of inconclusive pancreatobiliary cytology. Cancer Cytopathol. 2014 Vlajnic T, Andreozzi MC, Schneider S, Tornillo L, Karamitopoulou E, Lugli A, Ruiz C, Zlobec I, Terracciano L. VEGFA gene locus (6p12) amplification identifies a small but highly aggressive subgroup of colorectal cancer patients. Mod Pathol. 2011

Members List